SMYD3 and prostate cancer: It was very interesting to identify EZH2 and SMYD3 as the most significantly changed and overexpressed histone modifiers in prostate cancer, since the two modifications are antagonistic and correspond to repressive (H3K27me3) and active (H3K4me3) gene transcription, respectively.